Haizheng Pharmaceutical announced on December 12 that its wholly-owned subsidiary Haizheng Hangzhou Company has received the European Pharmacopeia applicability certification for everolimus APIs issued by the European Medicines Quality Administration.

Zhitongcaijing · 2d ago
Haizheng Pharmaceutical announced on December 12 that its wholly-owned subsidiary Haizheng Hangzhou Company has received the European Pharmacopeia applicability certification for everolimus APIs issued by the European Medicines Quality Administration.